Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizzia Raffaghello

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2013
Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastomaEmma Di Carlo, Paola Bocca, Laura Emionite, et al.
Oncogene|May 18, 2005
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implicationsLizzia Raffaghello, Ignazia Prigione, Paola Bocca, et al.
Stem Cells (Dayton, Ohio)|February 23, 2008
Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigensFabio Morandi, Lizzia Raffaghello, Giovanna Bianchi, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Immunogenicity of human neuroblastomaIgnazia Prigione, Maria Valeria Corrias, Irma Airoldi, et al.
Oncotarget|November 3, 2014
Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxiaAnnalisa Pezzolo, Danilo Marimpietri, Lizzia Raffaghello, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2023
Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in SarcoglycanopathiesAndrea Benzi, Serena Baratto, Cecilia Astigiano, et al.
Cancer Research|April 17, 2012
Expression of P2X7 receptor increases in vivo tumor growthElena Adinolfi, Lizzia Raffaghello, Anna Lisa Giuliani, et al.
Nature Protocols|July 7, 2017
Use of luciferase probes to measure ATP in living cells and animalsGiampaolo Morciano, Alba Clara Sarti, Saverio Marchi, et al.
Cancer Research|February 11, 2010
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic indexChanghan Lee, Fernando M Safdie, Lizzia Raffaghello, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2013
Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastomaEmma Di Carlo, Paola Bocca, Laura Emionite, et al.
Oncogene|May 18, 2005
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implicationsLizzia Raffaghello, Ignazia Prigione, Paola Bocca, et al.
Stem Cells (Dayton, Ohio)|February 23, 2008
Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigensFabio Morandi, Lizzia Raffaghello, Giovanna Bianchi, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Immunogenicity of human neuroblastomaIgnazia Prigione, Maria Valeria Corrias, Irma Airoldi, et al.
Oncotarget|November 3, 2014
Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxiaAnnalisa Pezzolo, Danilo Marimpietri, Lizzia Raffaghello, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2023
Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in SarcoglycanopathiesAndrea Benzi, Serena Baratto, Cecilia Astigiano, et al.
Cancer Research|April 17, 2012
Expression of P2X7 receptor increases in vivo tumor growthElena Adinolfi, Lizzia Raffaghello, Anna Lisa Giuliani, et al.
Nature Protocols|July 7, 2017
Use of luciferase probes to measure ATP in living cells and animalsGiampaolo Morciano, Alba Clara Sarti, Saverio Marchi, et al.
Cancer Research|February 11, 2010
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic indexChanghan Lee, Fernando M Safdie, Lizzia Raffaghello, et al.
Pageof 9